Methadone for the treatment of pain #75

Journal of Palliative Medicine

Volumn 6, Issue 4, 2003, Pages 620-621

  Gazelle, G ^a,b   Fine, Perry G ^c  

^a VistaCare   (United States)

^b Hospice of Greater Brockton   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE; MORPHINE;

ANALGESIA; CONSULTATION; DRUG CROSS TOLERANCE; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG INDICATION; DRUG TOLERANCE; DRUG USE; FAMILY COUNSELING; HUMAN; MEDICAL SPECIALIST; NEUROPATHIC PAIN; PAIN; PATIENT EDUCATION; PRESCRIPTION; SHORT SURVEY; TREATMENT INDICATION;

EID: 0041974973     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/109662103768253740     Document Type: Short Survey

References (5)

1. Ayonrinde OT, Bridge DT: The rediscovery of methadone for cancer pain management. Med J Aust 2000;173:536-540.
2. Bruera E, Sweeney C: Methadone use in cancer patients with pain: A review. J Palliat Med 2002;5:127-138.
3. Iribarne C, Dreano Y, Bardou LG, Menez JF, Berthou F: Interaction of methadone with substrates of human hepatic cytochrome P450 3A4. Toxicology 1997;117:13-23.
4. Morley JS, Makin MK: The use of methadone in cancer pain poorly responsive to other opioids. Pain Rev 1998;5:51-58.
5. Rowbotham MC: The debate over opioids and neuropathic pain. In Kalso E, McQuay HJ, Wiesenfeld-Hallin Z (eds): Opioid Sensitivity of Chronic Noncancer Pain, Progress in Pain Research and Management, Vol. 14. Seattle; IASP Press, 1999; pp. 307-317.